Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Impact BioMedical, Inc. (IBO)
Impact BioMedical Inc is implementing automated screening to accelerate drug time-to-market, which impacts quarterly EPS growth rates. The application of AI in biodata analysis optimizes preclinical stages, and the current level is approximately 95.30. The holding's success now depends on patent protection and asset licensing, which stabilizes investor confidence in earnings per share dynamics.
Rincian analitis perusahaan Impact BioMedical, Inc. (IBO)
- rega saham lan prakiraan rega para ahli:
- rincian kapitalisasi pasar:
- data kapitalisasi buku:
- rincian struktur utang lan likuiditas bisnis:
Utang marang Ekuitas Impact BioMedical Inc|IBO - Kewajiban jangka dawa marang ekuitas|Utang jangka cendhak marang modal Impact BioMedical Inc|IBO - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Impact BioMedical|IBO - Kewajiban jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Impact BioMedical|Indikator likuiditas cepet impactbiomedinc.com
- indikator bathi lan kelipatan valuasi:
IBO - Bathi pungkasan|Proyeksi bathi mangsa ngarep Impact BioMedical Inc|IBO - Rasio rega marang bathi|Pangali Forward P/E Impact BioMedical|IBO - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Impact BioMedical|IBO - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Impact BioMedical|IBO - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan impactbiomedinc.com|IBO - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Impact BioMedical Inc
Analisis wiwitan perusahaan:Impact BioMedical - IBO
The specificity of Impact BioMedical Inc (IBO) lies in the prolonged development cycles of proprietary therapies, which necessitates strict control over investment efficiency. This indicator measures the rate of change in net earnings per share, allowing for the identification of a gap between operating revenue and actual yield, which, through a cross-section of quarterly EPS dynamics, helps determine the risk of asset overvaluation.
Pesaing utama
HLN: Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Kenvue Inc (KVUE)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Verona Pharma Corp|MENS: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan LGND|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan amneal.com|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Perrigo PRGO|ALVO - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|LQDA - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan GLPG|ANIP: Wutah bathi EPS kuartalan|mannkindcorp.com (MNKD) - Wutah bathi EPS kuartalan|AMPH (Amphastar Pharmaceuticals, Inc.) - Wutah bathi EPS kuartalan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan Pacira Pharmaceuticals (PCRX)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan SPRY (ARS Pharma)|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan TBPH|Aquestive Therapeutics - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan SCPH|Tectonic - Wutah bathi EPS kuartalan|TNXP: Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|SXTC: Wutah bathi EPS kuartalan|EPRX - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan BioHarvest Sciences|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan invizyne.com EXOZ|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Oramed Pharmaceuticals (ORMP)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan enterabio.com ENTX|Wutah bathi EPS kuartalan HYFT (MindWalk)|ABVC BioPharma, Inc (ABVC) - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Cumberland Pharmaceuticals - Wutah bathi EPS kuartalan|QNTM (quantumbiopharma.com) - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|FGEN: Wutah bathi EPS kuartalan|TELO - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|RANI (Rani Therapeutics Holdings) - Wutah bathi EPS kuartalan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan Synergy CHC Corporation (SNYR)|Wutah bathi EPS kuartalan RLYB|Wutah bathi EPS kuartalan lexariabioscience.com (LEXX)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Pulmatrix PULM|Pheton Holdings Limited - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|APM: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan LYRA (Lyra Therapeutics Inc)|TNFA: Wutah bathi EPS kuartalan|YCBD - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan PainReform|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan CYTO (Auris Medical)|Wutah bathi EPS kuartalan LIPO|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan OptiNose Corp OPTN|Wutah bathi EPS kuartalan PIRS (Pieris Pharmaceuticals)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan procapsgroup.com (PROC)|Petros Pharmaceuticals, Inc. - Wutah bathi EPS kuartalan|QLI: Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|ACELYRIN, Inc. (SLRN) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan TFF Pharmaceuticals, Inc (TFFP)
